Alnylam Pharmaceuticals (NASDAQ:ALNY) Now Covered by Redburn Atlantic
Redburn Atlantic began coverage on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) in a research report report published on Monday, MarketBeat.com reports. The firm issued a buy rating and a $353.00 price target on the biopharmaceutical company’s stock. ALNY has been the topic of several other research reports. Morgan Stanley lifted their price objective […]
Redburn Atlantic began coverage on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) in a research report report published on Monday, MarketBeat.com reports. The firm issued a buy rating and a $353.00 price target on the biopharmaceutical company’s stock. ALNY has been the topic of several other research reports. Morgan Stanley lifted their price objective […]
